Yahoo Web Search

Search results

      • Anavex Life Sciences (AVXL -1.80%) is a small-cap stock with big ambitions. It has a potential Alzheimer's treatment that fared well in recent trials and could be a game-changer for the business. But the company remains unprofitable, and the stock is heavily shorted and volatile.
      www.fool.com › investing › 2023/02/23
  1. People also ask

  2. Feb 23, 2023 · Anavex Life Sciences ( AVXL -1.80%) is a small-cap stock with big ambitions. It has a potential Alzheimer's treatment that fared well in recent trials and could be a game-changer for the...

    • David Jagielski
  3. Jan 24, 2024 · Anavex Life Sciences (AVXL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the...

  4. Dec 17, 2022 · Free Article. Anavex Life Sciences Stock Could 5x Before 2025 -- Here's Why. By Alex Carchidi – Dec 17, 2022 at 9:15AM. Key Points. Anavex's latest clinical trial update didn't go over well...

  5. Jun 14, 2021 · Shares of Anavex Life Sciences ( AVXL 2.56%) got a serious boost on Monday. Two of the company's leading pipeline drugs were positively highlighted in peer-reviewed research that was newly...

  6. Jun 26, 2020 · Anavex Life Sciences currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over...

  7. Jan 24, 2024 · January 24, 2024 — 12:00 pm EST. Written by Zacks Equity Research for Zacks -> Investors might want to bet on Anavex Life Sciences (AVXL), as it has been recently upgraded to a Zacks Rank #1...

  8. Mar 8, 2023 · Mar. 08, 2023 8:50 AM ET Anavex Life Sciences Corp. (AVXL) Stock 29 Comments. 15 Likes. Avisol Capital Partners. Investing Group Leader. Summary. Anavex seems to have effectively handled...

  1. People also search for